BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38723375)

  • 1. [Pediatric myasthenia with ocular involvement].
    Prud'homme L; Gitiaux C; Barnerias C; Orssaud C; Bremond-Gignac D; Robert MP
    J Fr Ophtalmol; 2024 May; 47(7):104202. PubMed ID: 38723375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Ocular Features of Pediatric Myasthenias.
    Mansukhani SA; Bothun ED; Diehl NN; Mohney BG
    Am J Ophthalmol; 2019 Apr; 200():242-249. PubMed ID: 30653958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and paraclinical profile of autoimmune myasthenia gravis in Ouagadougou, Burkina Faso].
    Lompo DL; Éric Some N; Ouedraogo AM; Yonli RP; Diallo O; Napon C; Millogo A; Kabore J
    Med Trop Sante Int; 2021 Dec; 1(4):. PubMed ID: 35685858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of pediatric ocular myasthenia gravis.
    Ortiz S; Borchert M
    Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes and surgical treatment of diplopia and strabismus secondary to myasthenia gravis.
    Merino Sanz P; Del Cerro Pérez I; Alan Peinado G; Gómez de Liaño Sánchez P
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Mar; 94(3):107-113. PubMed ID: 30580990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis.
    Alam MS; Devi Nivean P
    GMS Ophthalmol Cases; 2017; 7():Doc07. PubMed ID: 28293536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics and ocular findings in children with myasthenia.
    Arruti N; Munot P; Bowman R
    Eye (Lond); 2023 Mar; 37(4):700-704. PubMed ID: 35338356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic, serological and clinical evaluation of childhood myasthenia syndromes- single center subgroup analysis experience in Turkey.
    Özsoy Ö; Cinleti T; Günay Ç; Sarıkaya Uzan G; Giray Bozkaya Ö; Çağlayan AO; Hız Kurul S; Yiş U
    Acta Neurol Belg; 2023 Dec; 123(6):2325-2335. PubMed ID: 37656362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia.
    Parr JR; Andrew MJ; Finnis M; Beeson D; Vincent A; Jayawant S
    Arch Dis Child; 2014 Jun; 99(6):539-42. PubMed ID: 24500997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing outcome measures of disease activity in pediatric myasthenia.
    Prior DE; Cooper BA; Zhang B; Ghosh PS
    Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior oblique muscle paresis as a sign of myasthenia gravis.
    Almog Y; Ben-David M; Nemet AY
    J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis in childhood.
    Gamio S; Garcia-Erro M; Vaccarezza MM; Minella JA
    Binocul Vis Strabismus Q; 2004; 19(4):223-31. PubMed ID: 15530139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia, from the internist's point of view].
    Eymard B
    Rev Med Interne; 2014 Jul; 35(7):421-9. PubMed ID: 24112993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and surgical treatment for ocular myasthenia.
    Benatar M; Kaminski H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.